Logo.png
Adial Pharmaceuticals to Present at the 2024 ThinkEquity Conference
23 oct. 2024 09h00 HE | Adial Pharmaceuticals, Inc.
Adial Pharmaceuticals to Present at the 2024 ThinkEquity Conference
Logo.png
Harvard Apparatus Regenerative Technology Announces $5 Million Financing to Continue Clinical Trial
26 août 2024 14h36 HE | Harvard Apparatus Regenerative Technology, Inc.
Holliston, MA, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Harvard Apparatus Regenerative Technology, Inc. (OTCQB: HRGN) (“Harvard Apparatus Regenerative Technology” or the “Company”), a clinical-stage...
Logo.png
Vyant Bio Announces 77,522 Votes Needed to Approve Sale of Assets 175,721 Votes Needed to Approve Winddown of Business Adjournment of Special Meeting of Stockholders
11 oct. 2023 11h45 HE | Vyant Bio, Inc.
CHERRY HILL, N.J., Oct. 11, 2023 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (OTC: VYNT), today announced that its special meeting of stockholders on September 28, 2023 (the...
cmi_logo.png
[Latest] Global Regenerative Medicine Market Size/Share Worth USD 174.72 Billion by 2032 at a 22.8% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
10 juil. 2023 13h30 HE | Custom Market Insights
Austin, TX, USA, July 10, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Regenerative Medicine Market Size, Trends and Insights By Product (Serum-free...
ChildCare Education Institute Offers No-Cost Online Course on Attention Deficit Hyperactivity Disorder
ChildCare Education Institute Offers No-Cost Online Course on Attention Deficit Hyperactivity Disorder
01 juin 2023 00h58 HE | ChildCare Education Institute
ATLANTA, GA, June 01, 2023 (GLOBE NEWSWIRE) -- ChildCare Education Institute® (CCEI), one of the largest online training providers dedicated exclusively to the early care and education workforce,...
visiongain Logo.png
Rare Diseases Market is projected to grow at a CAGR of 12.27% by 2033: Visiongain
17 mai 2023 11h24 HE | Visiongain Reports Ltd
As per the report by Visiongain, the Rare Diseases Market was valued at US$188.58 billion in 2022 and is projected to grow at a CAGR of 12.27% during the forecast period 2023-2033.  Visiongain has...
visiongain Logo.png
Rare Diseases Market is projected to grow at a CAGR of 12.27% by 2033: Visiongain Reports Ltd
31 mars 2023 11h35 HE | Visiongain Reports Ltd
Visiongain has published a new report entitled Rare Diseases 2023-2033. It includes profiles of Rare Diseases and Forecasts Market Segment by Diseases (Cancer, Metabolic Diseases, Neurological...
MaximizeMarketResearch
Bleeding Disorders Treatment Market size to hit USD 29.8 Bn by 2029 at a CAGR of 8.5 percent – says Maximize Market Research
30 mars 2023 07h34 HE | MAXIMIZE MARKET RESEARCH PRIVATE LIMITED
Pune, March 30, 2023 (GLOBE NEWSWIRE) -- A global Healthcare business-consulting firm, Maximize Market research, has published a market intelligence and competitive landscape report on the “Bleeding...
visiongain Logo.png
Rare Diseases Market is projected to grow at a CAGR of 12.27% by 2033: Visiongain Reports Ltd
02 mars 2023 07h48 HE | Visiongain Reports Ltd
Visiongain has published a new report entitled Rare Diseases 2023-2033. It includes profiles of Rare Diseases and Forecasts Market Segment by Diseases (Cancer, Metabolic Diseases, Neurological...
Straits Research Pvt Ltd
Fungal Keratitis Treatment Market Size is projected to reach USD 1.32 Billion by 2030, growing at a CAGR of 6%: Straits Research
14 juil. 2022 13h00 HE | Straits Research
New York, United States, July 14, 2022 (GLOBE NEWSWIRE) -- The fungal keratitis treatment market is driven by the increasing prevalence of such diseases worldwide, rising awareness of the potential...